StockUS listing USBOEUFPINKHealthcareQuality Compounder

Bonesupport Holding AB (publ)(BOEUF) Stock Analysis | Healthcare

USD --+0.00%
Reward75High
Risk23Low
75%Data
Strong 15% profit margin · Revenue growing 14% YoY
USD —+0.00 (+0.00%) Previous close · PINK
Market cap 1.57Bn
Reward Ratingⓘ75 High reward assessment · 75% data coverage
Top 10% of stocksView factors
Risk Ratingⓘ23 Low risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on BOEUF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Bonesupport Holding AB (publ)?

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

AI Brief Pro

The brief on Bonesupport Holding AB (publ)

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Bonesupport Holding AB (publ)?

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.57B, and a P/E ratio of 79.3x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (75)

Similar stocks to compare

A short list of Medical Instruments & Supplies names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryMedical Instruments & Supplies
P/E Ratio79.3333
Beta0.453
Insider Activity
12M windowNo data
No insider activity data available for this ticker.